Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18513
Country/Region: Kenya
Year: 2018
Main Partner: Liverpool VCT, Care and Treatment
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $5,727,557 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $831,523
Care: TB/HIV (HVTB) $51,123
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $59,097
Testing: HIV Testing and Counseling (HVCT) $627,397
Sexual Prevention: Other Sexual Prevention (HVOP) $3,594,597
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $46,905
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $516,915
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 213
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 213
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 213
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 213
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 637
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 637
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 213
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 213
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 2,123
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 2,125
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2019 212
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 213
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 2,973
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 2,972
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2019 214
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2019 213
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 637
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 637
GEND_GBV 25-29, Male, Physical and/or Emotional Violence 2019 212
GEND_GBV 25-29, Male, Sexual Violence (Post-Rape Care) 2019 212
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 637
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 637
GEND_GBV 30-34, Male, Physical and/or Emotional Violence 2019 212
GEND_GBV 30-34, Male, Sexual Violence (Post-Rape Care) 2019 212
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 637
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 637
GEND_GBV 35-39, Male, Physical and/or Emotional Violence 2019 212
GEND_GBV 35-39, Male, Sexual Violence (Post-Rape Care) 2019 212
GEND_GBV 40-49, Female, Physical and/or Emotional Violence 2019 637
GEND_GBV 40-49, Female, Sexual Violence (Post-Rape Care) 2019 637
GEND_GBV 40-49, Male, Physical and/or Emotional Violence 2019 212
GEND_GBV 40-49, Male, Sexual Violence (Post-Rape Care) 2019 212
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2019 211
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2019 214
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2019 213
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2019 214
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 6,297
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 10,622
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 10,620
GEND_GBV Number of people receiving post-GBV care 2019 21,239
HTS_SELF 2019 21,511
HTS_SELF 10-14, Female, Directly-Assisted 2019 63
HTS_SELF 15-19, Female, Directly-Assisted 2019 1,149
HTS_SELF 15-19, Female, Unassisted 2019 1,149
HTS_SELF 15-19, Male, Directly-Assisted 2019 383
HTS_SELF 15-19, Male, Unassisted 2019 383
HTS_SELF 20-24, Female, Directly-Assisted 2019 1,149
HTS_SELF 20-24, Female, Unassisted 2019 1,149
HTS_SELF 20-24, Male, Directly-Assisted 2019 383
HTS_SELF 20-24, Male, Unassisted 2019 383
HTS_SELF 25-29, Female, Directly-Assisted 2019 1,149
HTS_SELF 25-29, Female, Unassisted 2019 1,149
HTS_SELF 25-29, Male, Directly-Assisted 2019 383
HTS_SELF 25-29, Male, Unassisted 2019 383
HTS_SELF 30-34, Female, Directly-Assisted 2019 1,149
HTS_SELF 30-34, Female, Unassisted 2019 1,149
HTS_SELF 30-34, Male, Directly-Assisted 2019 383
HTS_SELF 30-34, Male, Unassisted 2019 383
HTS_SELF 35-39, Female, Directly-Assisted 2019 1,149
HTS_SELF 35-39, Female, Unassisted 2019 1,149
HTS_SELF 35-39, Male, Directly-Assisted 2019 383
HTS_SELF 35-39, Male, Unassisted 2019 383
HTS_SELF 40-49, Female, Directly-Assisted 2019 1,149
HTS_SELF 40-49, Female, Unassisted 2019 1,149
HTS_SELF 40-49, Male, Directly-Assisted 2019 383
HTS_SELF 40-49, Male, Unassisted 2019 383
HTS_SELF 50+, Female, Directly-Assisted 2019 1,149
HTS_SELF 50+, Female, Unassisted 2019 1,149
HTS_SELF 50+, Male, Directly-Assisted 2019 383
HTS_SELF 50+, Male, Unassisted 2019 383
HTS_SELF Directly-Assisted 2019 10,787
HTS_SELF FSW, Directly-Assisted 2019 14,372
HTS_SELF MSM, Directly-Assisted 2019 3,218
HTS_SELF PWID, Directly-Assisted 2019 1,287
HTS_SELF Unassisted 2019 10,724
HTS_SELF Unassisted - Other 2019 1,073
HTS_SELF Unassisted - Self 2019 5,362
HTS_SELF Unassisted - Sex Partner 2019 4,289
HTS_TST 25-29, Female, Negative 2019 1
HTS_TST 25-29, Female, Negative 2019 326
HTS_TST 25-29, Female, Negative 2019 244
HTS_TST 25-29, Female, Negative 2019 1
HTS_TST 25-29, Female, Negative 2019 2
HTS_TST 25-29, Male, Negative 2019 290
HTS_TST 25-29, Male, Negative 2019 5,038
HTS_TST 25-29, Male, Negative 2019 33
HTS_TST 25-29, Male, Negative 2019 1,191
HTS_TST 30-34, Female, Negative 2019 1
HTS_TST 30-34, Female, Negative 2019 326
HTS_TST 30-34, Female, Negative 2019 280
HTS_TST 30-34, Female, Negative 2019 1
HTS_TST 30-34, Female, Negative 2019 2
HTS_TST 30-34, Male, Negative 2019 348
HTS_TST 30-34, Male, Negative 2019 6,045
HTS_TST 30-34, Male, Negative 2019 40
HTS_TST 30-34, Male, Negative 2019 1,430
HTS_TST 35-39, Female, Negative 2019 326
HTS_TST 35-39, Female, Negative 2019 69
HTS_TST 35-39, Male, Negative 2019 1,430
HTS_TST 35-39, Male, Negative 2019 348
HTS_TST 35-39, Male, Negative 2019 6,045
HTS_TST 35-39, Male, Negative 2019 40
HTS_TST 40-49, Female, Negative 2019 326
HTS_TST 40-49, Female, Negative 2019 69
HTS_TST 40-49, Male, Negative 2019 477
HTS_TST 40-49, Male, Negative 2019 116
HTS_TST 40-49, Male, Negative 2019 2,016
HTS_TST 40-49, Male, Negative 2019 13
HTS_TST By Key Population: FSW, Negative 2019 15,724
HTS_TST By Key Population: MSM, Negative 2019 1,198
HTS_TST By Key Population: PWID, Negative 2019 200
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 74,407
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 580
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 108
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 1,996
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 348
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 58
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 1,274
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 754
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 4,388
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 2,415
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 238
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 17
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 583
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 1,162
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 7
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 9
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 3
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 1
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 17
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 15
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 58
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 55
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 7
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 59
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 253
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 74
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 42
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 4,766
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 2,139
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 16,420
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 6,843
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 35
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 1,007
HTS_TST_POS 25-29, Female, Positive 2019 5
HTS_TST_POS 25-29, Female, Positive 2019 2
HTS_TST_POS 25-29, Male, Positive 2019 20
HTS_TST_POS 25-29, Male, Positive 2019 91
HTS_TST_POS 25-29, Male, Positive 2019 54
HTS_TST_POS 25-29, Male, Positive 2019 28
HTS_TST_POS 30-34, Female, Positive 2019 6
HTS_TST_POS 30-34, Female, Positive 2019 2
HTS_TST_POS 30-34, Male, Positive 2019 33
HTS_TST_POS 30-34, Male, Positive 2019 22
HTS_TST_POS 30-34, Male, Positive 2019 110
HTS_TST_POS 30-34, Male, Positive 2019 64
HTS_TST_POS 35-39, Female, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 33
HTS_TST_POS 35-39, Male, Positive 2019 22
HTS_TST_POS 35-39, Male, Positive 2019 110
HTS_TST_POS 35-39, Male, Positive 2019 64
HTS_TST_POS 40-49, Female, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 10
HTS_TST_POS 40-49, Male, Positive 2019 8
HTS_TST_POS 40-49, Male, Positive 2019 38
HTS_TST_POS 40-49, Male, Positive 2019 21
HTS_TST_POS By Key Population: FSW, Positive 2019 585
HTS_TST_POS By Key Population: MSM, Positive 2019 27
HTS_TST_POS By Key Population: PWID, Positive 2019 5
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 23
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 77
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 26
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 18
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 59
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 51
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 105
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 82
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 73
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 40
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 255
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 126
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 18
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 12,810
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 41
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 375
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 1,278
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 14,504
OVC_SERV Age/Sex: <1 2019 20
OVC_SERV Age/Sex: 1-9 2019 4,255
OVC_SERV Age/Sex: 10-14 Female 2019 3,335
OVC_SERV Age/Sex: 10-14 Male 2019 2,655
OVC_SERV Age/Sex: 15-17 Female 2019 4,609
OVC_SERV Age/Sex: 15-17 Male 2019 1,685
OVC_SERV By: Age/sex: 18-24 Female 2019 2,739
OVC_SERV By: Age/sex: 25+ Female 2019 2
OVC_SERV By: Age/sex: Male 18-24 2019 1,095
OVC_SERV By: Age/sex: Male 25+ 2019 4
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2019 20,402
OVC_SERV Program Completion: Active 2019 20,348
OVC_SERV Program Completion: Graduation 54 Number of orphans and vulnerable children (<18 years old) whose HIV status is known or unknown by the OVC implementing partner. 16,560 Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2019 20,402
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 10-14 2019 254
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 15-17 2019 556
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2019 1,091
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 10-14 2019 221
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 15-17 2019 137
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 18-24 2019 94
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2019 1,406
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2019 5,279
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 18-24 2019 3,339
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 10-14 2019 327
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 15-17 2019 213
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 18-24 2019 122
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 10-14 2019 2,876
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 15-17 2019 11,585
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 18-24 2019 7,530
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 10-14 2019 332
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 15-17 2019 212
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 18-24 2019 135
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 10-14 2019 277
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 15-17 2019 58
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 18-24 2019 28
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 10-14 2019 83
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 15-17 2019 52
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 18-24 2019 36
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2019 414
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2019 448
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2019 242
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 10-14 2019 544
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 15-17 2019 157
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 18-24 2019 71
OVC_SERV Sum of Age/Sex disaggregates 2019 12,284
PP_PREV 25-29, Female 2019 2,312
PP_PREV 25-29, Male 2019 2,885
PP_PREV 30-34, Female 2019 2,312
PP_PREV 30-34, Male 2019 2,885
PP_PREV 35-39, Female 2019 2,312
PP_PREV 35-39, Male 2019 2,885
PP_PREV 40-49, Female 2019 2,312
PP_PREV 40-49, Male 2019 2,885
PP_PREV Age/sex: 10-14 Female 2019 1,502
PP_PREV Age/sex: 10-14 Male 2019 215
PP_PREV Age/sex: 15-19 Female 2019 7,698
PP_PREV Age/sex: 15-19 Male 2019 1,814
PP_PREV Age/sex: 20-24 Female 2019 7,197
PP_PREV Age/sex: 20-24 Male 2019 4,150
PP_PREV Age/sex: 50+ Female 2019 1,175
PP_PREV Age/sex: 50+ Male 2019 1,211
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 45,754
PP_PREV Sum of Age/Sex disaggregates 2019 24,962
PrEP_NEW 25-29, Female 2019 75
PrEP_NEW 25-29, Male 2019 31
PrEP_NEW 30-34, Female 2019 54
PrEP_NEW 30-34, Male 2019 41
PrEP_NEW 35-39, Female 2019 54
PrEP_NEW 35-39, Male 2019 41
PrEP_NEW 40-49, Female 2019 54
PrEP_NEW 40-49, Male 2019 31
PrEP_NEW Female 15-19 2019 126
PrEP_NEW Female 20-24 2019 433
PrEP_NEW Female 50+ 2019 21
PrEP_NEW FSW 2019 147
PrEP_NEW Male 15-19 2019 11
PrEP_NEW Male 20-24 2019 64
PrEP_NEW Male 50+ 2019 21
PrEP_NEW MSM 2019 75
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 1,057
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 7
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 9
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 17
TB_PREV By Age/Sex (Numerator): <15, Female 2019 11
TB_PREV By Age/Sex (Numerator): <15, Male 2019 11
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 141
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 93
TB_PREV IPT, Life-long ART, New, Positive 2019 257
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 257
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 261
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 11
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 16
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 143
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 90
TB_PREV_den IPT, Life-long ART, New, Positive 2019 261
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 6
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 8
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 16
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 16
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 6
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 8
TX_CURR 25-29, Female, Positive 2019 599
TX_CURR 25-29, Male, Positive 2019 218
TX_CURR 30-34, Female, Positive 2019 454
TX_CURR 30-34, Male, Positive 2019 338
TX_CURR 35-39, Female, Positive 2019 454
TX_CURR 35-39, Male, Positive 2019 338
TX_CURR 40-49, Female, Positive 2019 311
TX_CURR 40-49, Male, Positive 2019 338
TX_CURR Age/Sex: <1 2019 2
TX_CURR Age/Sex: <1-9 2019 67
TX_CURR Age/Sex: 10-14 Female 2019 26
TX_CURR Age/Sex: 10-14 Male 2019 24
TX_CURR Age/Sex: 15-19 Female 2019 152
TX_CURR Age/Sex: 15-19 Male 2019 68
TX_CURR Age/Sex: 20-24 Female 2019 419
TX_CURR Age/Sex: 20-24 Male 2019 92
TX_CURR Age/Sex: 50+ Female 2019 249
TX_CURR Age/Sex: 50+ Male 2019 124
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 4,272
TX_CURR Sum of age/sex disaggregates 2019 220
TX_NEW 25-29, Female, Positive 2019 1
TX_NEW 25-29, Male, Positive 2019 100
TX_NEW 30-34, Female, Positive 2019 1
TX_NEW 30-34, Male, Positive 2019 119
TX_NEW 35-39, Male, Positive 2019 119
TX_NEW 40-49, Male, Positive 2019 39
TX_NEW Breastfeeding status 2019 24
TX_NEW By Age/Sex: <1 2019 4
TX_NEW By Age/Sex: 1-9 2019 2
TX_NEW By Age/Sex: 10-14 Female 2019 1
TX_NEW By Age/Sex: 10-14 Male 2019 1
TX_NEW By Age/Sex: 15-19 Female 2019 38
TX_NEW By Age/Sex: 15-19 Male 2019 41
TX_NEW By Age/Sex: 20-24 Female 2019 385
TX_NEW By Age/Sex: 20-24 Male 2019 133
TX_NEW By Age/Sex: 50+ Male 2019 22
TX_NEW FSW 2019 11
TX_NEW MSM 2019 2
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 1,012
TX_NEW People in prisons and other enclosed settings 2019 1
TX_NEW Pregnancy status 2019 86
TX_NEW Sum of Age/Sex disaggregates 2019 621
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 3,458
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 48
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 5
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 46
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 5
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 2,081
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 107
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 1,100
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 66
TX_PVLS_den Denominator: Indication: Routine 2019 3,275
TX_PVLS_den Denominator: Indication: Targeted 2019 183
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 50
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 25
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 75
TX_RET Numerator by Status: Breastfeeding 2019 3
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 129
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 87
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 41
TX_RET_den Denominator by Status: Breastfeeding 2019 4
TX_RET_den Denominator by Status: Pregnant 2019 10
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 4,195
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 185
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 230
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 2,510
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 1,271
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 200
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 12
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 219
Cross Cutting Budget Categories and Known Amounts Total: $5,008,501
Key Populations: MSM and TG $157,100
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Key Populations: Sex Workers $157,109
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Gender: Gender Based Violence (GBV) $197,483
GBV Prevention
Implementation
Capacity building
Post GBV Care
Implementation
Capacity building
Gender: Gender Equality $246,854
Equity in HIV prevention, care, treatment and support
Implementation
Capacity building
Renovation $112,244
Motor Vehicles: Purchased $102,041
Adolescent Girls and Young Women (AGYW) $3,263,522
Human Resources for Health $772,148